Citations 3
An ex vivo chemoresponse assay predicts carboplatin-induced progression-free interval in ovarian cancer
Coleman, Rob, Herzog, Thomas J. , Hosford, S., Sevin, Bernd‐Uwe, Fiori, L., Gallion, Holly H., Wells, Alan
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5134-5134
Ex vivo chemoresponse assay of ovarian cancers predicts clinical outcome
Gallion, Holly H., Wa, Christopherson, Coleman, Rob, Herzog, Thomas J. , Sevin, Bernd‐Uwe, Fiori, L., Wells, Alan
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5074-5074
Heterogeneity in chemoresponsiveness of ovarian cancer as demonstrated by an ex vivo chemo response assay
Ochs, Robert, Gallion, Holly H., Coleman, Rob, Herzog, Thomas J. , Sevin, B.U., Schellhas, Helmut F., Wells, Alan
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5059-5059